• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

选择性剪接的组织因子不足以支持胚胎发育。

Alternatively spliced tissue factor is not sufficient for embryonic development.

作者信息

Sluka Susanna H M, Akhmedov Alexander, Vogel Johannes, Unruh Dusten, Bogdanov Vladimir Y, Camici Giovanni G, Lüscher Thomas F, Ruf Wolfram, Tanner Felix C

机构信息

Cardiovascular Research, Institute of Physiology, University of Zurich, Zurich, Switzerland; Center for Integrative Human Physiology, University of Zurich, Zurich, Switzerland.

Center for Integrative Human Physiology, University of Zurich, Zurich, Switzerland; Institute of Veterinary Physiology, University of Zurich, Zurich, Switzerland.

出版信息

PLoS One. 2014 May 30;9(5):e97793. doi: 10.1371/journal.pone.0097793. eCollection 2014.

DOI:10.1371/journal.pone.0097793
PMID:24879059
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC4039448/
Abstract

Tissue factor (TF) triggers blood coagulation and is translated from two mRNA splice isoforms, encoding membrane-anchored full-length TF (flTF) and soluble alternatively-spliced TF (asTF). The complete knockout of TF in mice causes embryonic lethality associated with failure of the yolk sac vasculature. Although asTF plays roles in postnatal angiogenesis, it is unknown whether it activates coagulation sufficiently or makes previously unrecognized contributions to sustaining integrity of embryonic yolk sac vessels. Using gene knock-in into the mouse TF locus, homozygous asTF knock-in (asTFKI) mice, which express murine asTF in the absence of flTF, exhibited embryonic lethality between day 9.5 and 10.5. Day 9.5 homozygous asTFKI embryos expressed asTF protein, but no procoagulant activity was detectable in a plasma clotting assay. Although the α-smooth-muscle-actin positive mesodermal layer as well as blood islands developed similarly in day 8.5 wild-type or homozygous asTFKI embryos, erythrocytes were progressively lost from disintegrating yolk sac vessels of asTFKI embryos by day 10.5. These data show that in the absence of flTF, asTF expressed during embryonic development has no measurable procoagulant activity, does not support embryonic vessel stability by non-coagulant mechanisms, and fails to maintain a functional vasculature and embryonic survival.

摘要

组织因子(TF)触发血液凝固,由两种mRNA剪接异构体翻译而来,分别编码膜锚定的全长TF(flTF)和可溶性可变剪接TF(asTF)。小鼠TF的完全敲除会导致胚胎致死,这与卵黄囊脉管系统功能衰竭有关。尽管asTF在出生后血管生成中发挥作用,但尚不清楚它是否能充分激活凝血,或者是否对维持胚胎卵黄囊血管的完整性有此前未被认识到的作用。通过将基因敲入小鼠TF基因座,纯合asTF敲入(asTFKI)小鼠在缺乏flTF的情况下表达鼠asTF,在第9.5天至10.5天之间表现出胚胎致死性。第9.5天的纯合asTFKI胚胎表达asTF蛋白,但在血浆凝血试验中未检测到促凝血活性。尽管在第8.5天的野生型或纯合asTFKI胚胎中,α-平滑肌肌动蛋白阳性的中胚层以及血岛发育相似,但到第10.5天时,asTFKI胚胎解体的卵黄囊血管中的红细胞逐渐丢失。这些数据表明,在缺乏flTF的情况下,胚胎发育过程中表达的asTF没有可测量的促凝血活性,不能通过非凝血机制支持胚胎血管稳定性,也无法维持功能性脉管系统和胚胎存活。

相似文献

1
Alternatively spliced tissue factor is not sufficient for embryonic development.选择性剪接的组织因子不足以支持胚胎发育。
PLoS One. 2014 May 30;9(5):e97793. doi: 10.1371/journal.pone.0097793. eCollection 2014.
2
Alternatively spliced tissue factor and full-length tissue factor protect cardiomyocytes against TNF-α-induced apoptosis. alternatively spliced tissue factor and full-length tissue factor protect cardiomyocytes against TNF-α-induced apoptosis. alternatively 剪接的组织因子和全长组织因子可保护心肌细胞免受 TNF-α 诱导的凋亡。
J Mol Cell Cardiol. 2012 May;52(5):1056-65. doi: 10.1016/j.yjmcc.2012.01.015. Epub 2012 Jan 31.
3
Alternatively spliced tissue factor. A crippled protein in coagulation or a key player in non-haemostatic processes? alternatively spliced tissue factor. A crippled protein in coagulation or a key player in non-haemostatic processes?
Hamostaseologie. 2010 Aug;30(3):144-9.
4
Interplay between alternatively spliced Tissue Factor and full length Tissue Factor in modulating coagulant activity of endothelial cells.可变剪接的组织因子与全长组织因子在调节内皮细胞凝血活性中的相互作用。
Thromb Res. 2017 Aug;156:1-7. doi: 10.1016/j.thromres.2017.05.028. Epub 2017 May 25.
5
Expression of flTF and asTF splice variants in various cell strains and tissues.flTF 和 asTF 剪接变异体在各种细胞株和组织中的表达。
Mol Med Rep. 2019 Mar;19(3):2077-2086. doi: 10.3892/mmr.2019.9843. Epub 2019 Jan 10.
6
Splice variants of Tissue Factor and integrin-mediated signaling.组织因子和整合素介导的信号转导的剪接变体。
Thromb Res. 2012 May;129 Suppl 2:S34-7. doi: 10.1016/j.thromres.2012.02.027. Epub 2012 Mar 17.
7
Overexpression of alternatively spliced tissue factor induces the pro-angiogenic properties of murine cardiomyocytic HL-1 cells.组织因子剪接异构体的过表达诱导鼠心肌细胞 HL-1 的促血管生成特性。
Circ J. 2011;75(5):1235-42. doi: 10.1253/circj.cj-10-0783. Epub 2011 Mar 7.
8
Alternatively spliced tissue factor synergizes with the estrogen receptor pathway in promoting breast cancer progression.可变剪接的组织因子在促进乳腺癌进展过程中与雌激素受体途径协同作用。
J Thromb Haemost. 2015 Sep;13(9):1683-93. doi: 10.1111/jth.13049. Epub 2015 Jul 31.
9
Alternatively spliced tissue factor: discovery, insights, clinical implications. alternatively spliced tissue factor: 发现、见解、临床意义。
Front Biosci (Landmark Ed). 2011 Jun 1;16(8):3061-71. doi: 10.2741/3899.
10
Alternatively spliced tissue factor: a previously unknown piece in the puzzle of hemostasis.可变剪接的组织因子:止血谜题中一个前所未知的部分。
Trends Cardiovasc Med. 2006 Jul;16(5):177-82. doi: 10.1016/j.tcm.2006.03.005.

引用本文的文献

1
Hemostasis and endothelial functionality: the double face of coagulation factors.止血与血管内皮功能:凝血因子的双重作用。
Haematologica. 2024 Jul 1;109(7):2041-2048. doi: 10.3324/haematol.2022.282272.
2
Functional Characteristics and Regulated Expression of Alternatively Spliced Tissue Factor: An Update.可变剪接组织因子的功能特性与调控表达:最新进展
Cancers (Basel). 2021 Sep 16;13(18):4652. doi: 10.3390/cancers13184652.
3
Targeting clotting proteins in cancer therapy - progress and challenges.癌症治疗中针对凝血蛋白——进展与挑战

本文引用的文献

1
Alternatively spliced tissue factor contributes to tumor spread and activation of coagulation in pancreatic ductal adenocarcinoma.剪接组织因子有助于胰腺导管腺癌的肿瘤扩散和凝血激活。
Int J Cancer. 2014 Jan 1;134(1):9-20. doi: 10.1002/ijc.28327. Epub 2013 Jul 27.
2
Nonproteolytic properties of murine alternatively spliced tissue factor: implications for integrin-mediated signaling in murine models.鼠类可变剪接组织因子的非蛋白水解特性:对鼠类模型中整合素介导信号转导的影响。
Mol Med. 2012 Jul 18;18(1):771-9. doi: 10.2119/molmed.2011.00416.
3
P2X7 receptor signaling contributes to tissue factor-dependent thrombosis in mice.
Thromb Res. 2016 Apr;140 Suppl 1(Suppl 1):S1-7. doi: 10.1016/S0049-3848(16)30090-1.
P2X7 受体信号转导促进小鼠组织因子依赖性血栓形成。
J Clin Invest. 2011 Jul;121(7):2932-44. doi: 10.1172/JCI46129. Epub 2011 Jun 13.
4
Cortactin activation by FVIIa/tissue factor and PAR2 promotes endothelial cell migration.VIIa 组织因子和 PAR2 激活桩蛋白促进血管内皮细胞迁移。
Am J Physiol Regul Integr Comp Physiol. 2011 Mar;300(3):R577-85. doi: 10.1152/ajpregu.00137.2010. Epub 2010 Dec 15.
5
Alternatively spliced tissue factor induces angiogenesis through integrin ligation.可变剪接的组织因子通过整合素连接诱导血管生成。
Proc Natl Acad Sci U S A. 2009 Nov 17;106(46):19497-502. doi: 10.1073/pnas.0905325106. Epub 2009 Oct 29.
6
Human alternatively spliced tissue factor is not secreted and does not trigger coagulation.
J Thromb Haemost. 2009 Aug;7(8):1423-6. doi: 10.1111/j.1538-7836.2009.03521.x. Epub 2009 Jun 22.
7
Role of alternatively spliced tissue factor in pancreatic cancer growth and angiogenesis.可变剪接的组织因子在胰腺癌生长和血管生成中的作用。
Semin Thromb Hemost. 2008 Mar;34(2):161-9. doi: 10.1055/s-2008-1079256.
8
Splicing promotes rapid and efficient mRNA export in mammalian cells.剪接促进哺乳动物细胞中mRNA的快速高效输出。
Proc Natl Acad Sci U S A. 2008 Mar 4;105(9):3386-91. doi: 10.1073/pnas.0800250105. Epub 2008 Feb 20.
9
Inhibition of tissue factor signaling suppresses tumor growth.抑制组织因子信号传导可抑制肿瘤生长。
Blood. 2008 Jan 1;111(1):190-9. doi: 10.1182/blood-2007-07-101048. Epub 2007 Sep 27.
10
Alternatively spliced human tissue factor (asHTF) is not pro-coagulant.可变剪接的人组织因子(asHTF)不具有促凝血作用。
Thromb Haemost. 2007 Jan;97(1):11-4.